It doesn’t. Garnock would only have 3% of shares if he sold all his 2019 shares ratified by the S1. Big if. His track record with PharmaCan/Cronos shows he is much more likely to add shares via his warrant once Verus hits certain milestones like better funding and getting its own manufacturing up and running. In any case, he is such a big and conspicuously investor, he can’t really sell a share without tanking his own stock. As with Cronos, the more feasible strategy is to build the company until someone much bigger comes in for 49% or more.
Market Data 
Markets 
AI
